435 (Mesalamine Delayed-Release 800 mg)

Pill with imprint 435 is Brown, Capsule-shape and has been identified as Mesalamine Delayed-Release 800 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 800 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 435

Save up to 80% off prescription medications

Click here for your free Discount Card

Mesalamine Delayed-Release

Imprint

435

Strength

800 mg

Color

Brown

Size

19.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

5-aminosalicylates

Pregnancy Category

B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD

CSA Schedule

Not a controlled drug

Labeler / Supplier

Zydus Pharmaceuticals (USA) Inc.

Manufacturer

Cadila Healthcare Limited

National Drug Code (NDC)

70771-1110

Inactive Ingredients

acetyltributyl citrate, silicon dioxide, ferric oxide red, magnesium stearate, methacrylic acid, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, magnesium silicate, titanium dioxide, ferrosoferric oxide, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, shellac

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "435"

Metformin Hydrochloride

Acamprosate Calcium Delayed-Release

Zaldyon

View more

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer